Omilon Group Competitors

We’re moving our account on Jun 30! Connect with us at our ams account https://www.linkedin.com/company/ams-ag/ to continue getting our updates. ________________________________________ Join ams social media channels: Follow us on https://twitter.com/amsAnalog or Share with https://www.linkedin.com/company/ams-ag Follow us on https://www.facebook.com/amsAnalog ________________________________________ ams is a global leader in the design and manufacture of advanced sensor solutions. Our mission is to shape the world with sensor solutions by providing a seamless interface between humans and technology. ams’ high-performance sensor solutions drive applications requiring small form factor, low power, highest sensitivity and multi-sensor integration. Products include sensor solutions, sensor ICs, interfaces and related software for consumer, communications, industrial, medical, and automotive markets. With headquarters in Austria, ams employs over 3,300 people globally and serves more than 8,000 customers worldwide. ams is listed on the SIX Swiss stock exchange (ticker symbol: AMS). More information about ams can be found at www.ams.com.

Swift Medical is the world leader in digital wound care management, delivering advanced wound care visualization and touchless 3D measurement through its smartphone-ready Swift Skin and Wound software. Swift’s enterprise-grade solution streamlines clinical and administrative wound care management workflows, from image capture and automatic risk scoring to assessment scheduling and claims submission. Today, Skin and Wound has been adopted by more than 5,200 facilities. To learn how Swift has digitized and transformed wound care, visit https://swiftmedical.com.

Careplus (M) Sdn Bhd was incorporated in Malaysia on 30 March 2010 as a private limited company under the name of Careplus Group Sdn. Bhd. Subsequently, on 5 April 2010, we converted our status from a private limited company to a public limited company to facilitate our listing on the ACE Market of Bursa Securities. We are principally an investment holding company whilst our subsidiaries are involved in the manufacturing, processing and trading of gloves. Careplus has also on 5 February 2020 entered into a joint venture arrangement with Ansell Services (Asia) Sdn. Bhd. (“Ansell”) for the disposal, via a conditional SPA entered into between Careplus and Ansell, of 50% equity interest in Careplus (M) Sdn. Bhd. (“CMSB”), consisting of 14,550,000 ordinary shares in CMSB for a disposal consideration of approximately RM26.97 million, to be satisfied entirely by cash (“Disposal”). Upon completion of the Disposal and in accordance with the terms of the Shareholders’ Agreement entered into between Careplus, Ansell and CMSB, CMSB ceased to be a wholly-owned subsidiary of Careplus and became a 50% of joint venture of Careplus.